GlassScriptPhysician profile
Philip J Smelcer
NPI 1780864140
$1,801.89
in general payments reported to CMS, 2019-2025
24 companies · $411 in 2025
The $411 reported for 2025 was more than what 76% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $400 · 2020: $136 · 2021: $16.35 · 2022: $152 · 2023: $315 · 2024: $372 · 2025: $411.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,098.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,097.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $255.59 | 2019-2025 | Veozah, Myrbetriq |
| Sumitomo Pharma America, INC. | $229.18 | 2023-2025 | Myfembree, Gemtesa |
| Exeltis, USA INC. | $193.81 | 2020-2025 | Slynd |
| Agile Therapeutics, INC. | $160.77 | 2022-2024 | Twirla |
| Abbvie INC. | $148.28 | 2019-2023 | Liletta, Lo Loestrin Fe, Orilissa |
| Organon LLC | $108.98 | 2023-2025 | Nexplanon, Jada System |
| Coloplast Corp | $93.01 | 2019 | |
| Hologic Sales and Service, LLC | $77.77 | 2019-2025 | Thinprep 2000 Processor, Aptima |
| Allergan, INC. | $55.18 | 2019-2020 | |
| Therapeuticsmd, INC. | $54.44 | 2019-2022 | |
| Amag Pharmaceuticals, INC. | $53.18 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $47.20 | 2019-2025 | |
| Coopersurgical, INC. | $46.84 | 2019-2025 | Advincula Delineator Uterine Manipulator, Paragard T 380a |
| Pfizer INC. | $46.66 | 2024 | |
| Optumhealth Care Solutions, LLC | $39.06 | 2024-2025 | Eitan Medical, Vivify Health Care Team Portal 001 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lupin INC. | $31.52 | 2019 | |
| Merck Sharp & Dohme LLC | $28.99 | 2019-2020 | |
| Mayne Pharma Commercial LLC | $26.02 | 2023-2025 | |
| Supernus Pharmaceuticals, INC. | $18.90 | 2025 | Qelbree |
| Sage Therapeutics, LLC | $18.90 | 2025 | Zurzuvae |
| Exact Sciences Corporation | $18.68 | 2025 | Cologuard Collection Kit |
| Shield Therapeutics INC | $18.39 | 2024 | |
| Myovant Sciences INC. | $16.35 | 2021 | |
| Mylan Pharmaceuticals INC. | $14.19 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Philip Smelcer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.